# Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis

Study · id `cardio:ct-nct06243133` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06243133](<https://clinicaltrials.gov/study/NCT06243133>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06243133

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1100 participants.

## Technical summary

Registry record NCT06243133. Randomized; single masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2026-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1100 participants (planned count; ClinicalTrials.gov record NCT06243133, source copy `cardio:ctgov-nct06243133-2024-06-18`, retrieved 2026-10-26)
- Planned start: 2024-07-01 (anticipated) (ClinicalTrials.gov record NCT06243133, source copy `cardio:ctgov-nct06243133-2024-06-18`, retrieved 2026-10-26)
- Primary completion: 2026-03-31 (anticipated) (ClinicalTrials.gov record NCT06243133, source copy `cardio:ctgov-nct06243133-2024-06-18`, retrieved 2026-10-26)
- Completion: 2026-03-31 (anticipated) (ClinicalTrials.gov record NCT06243133, source copy `cardio:ctgov-nct06243133-2024-06-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06243133, source copy `cardio:ctgov-nct06243133-2024-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06243133-2024-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
- Acronym: PATH-ICAS
- Condition: Ischemic Stroke
- Condition: Intracranial Arteriosclerosis
- Condition: Secondary Prevention
- Condition: Antiplatelet Drug
- Intervention (Drug): clopidogrel for 90 days combined with aspirin for 90 days
- Intervention (Drug): clopidogrel for 30 days combined with aspirin for 90 days
- Lead sponsor: Sichuan Provincial People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Sichuan Provincial People's Hospital (`cardio:org-sichuan-provincial-people-s-hospital`)

## Provenance

Content hash: d780ac7955c7e501c91526103df18200617a7557cf060516331dc8eb2a91461b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
